abstract |
The invention relates to a transdermal system for the delivery of 5-HT¶3¶ receptor antagonists, which is characterized in that it is a composition of a 5-HT¶3¶ receptor antagonist as an active ingredient, tea tree oil, a water-miscible solvent and contains water. |